Skip to main content

Advertisement

SpringerLink
Log in

IgA nephropathy and oxidative stress: news on clinically evaluated biomarkers hits the stage

  • Nephrology – Translational Section
  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Suzuki H et al (2011) The pathophysiology of IgA nephropathy. J Am Soc Nephrol 22(10):1795–1803

    Article  PubMed  CAS  Google Scholar 

  2. Mestecky J et al (2007) IgA nephropathy: current views of immune complex formation. Contrib Nephrol 157:56–63

    PubMed  CAS  Google Scholar 

  3. Moldoveanu Z et al (2007) Patients with IgA nephropathy have increased serum galactose-deficient IgA1 levels. Kidney Int 71(11):1148–1154

    Article  PubMed  CAS  Google Scholar 

  4. Coppo R, Feehally J, Glassock RJ (2010) IgA nephropathy at two score and one. Kidney Int 77(3):181–186

    Article  PubMed  CAS  Google Scholar 

  5. Gharavi AG et al (2008) Aberrant IgA1 glycosylation is inherited in familial and sporadic IgA nephropathy. J Am Soc Nephrol 19(5):1008–1014

    Article  PubMed  Google Scholar 

  6. Camilla R et al (2011) Oxidative stress and galactose-deficient IgA1 as markers of progression in IgA nephropathy. Clin J Am Soc Nephrol 6(8):1903–1911

    Article  PubMed  CAS  Google Scholar 

  7. Berger J, Hinglais N (1968) Intercapillary deposits of IgA–IgG. J Urol Nephrol (Paris) 74(9):694–695

    CAS  Google Scholar 

  8. D’Amico G (1987) The commonest glomerulonephritis in the world: IgA nephropathy. Q J Med 64(245):709–727

    PubMed  Google Scholar 

  9. Suzuki K et al (2003) Incidence of latent mesangial IgA deposition in renal allograft donors in Japan. Kidney Int 63(6):2286–2294

    Article  PubMed  Google Scholar 

  10. Waldherr R et al (1989) Frequency of mesangial IgA deposits in a non-selected autopsy series. Nephrol Dial Transpl 4(11):943–946

    CAS  Google Scholar 

  11. Barratt J et al (2009) Immune complex formation in IgA nephropathy: a case of the ‘right’ antibodies in the ‘wrong’ place at the ‘wrong’ time? Nephrol Dial Transpl 24(12):3620–3623

    Article  Google Scholar 

  12. Floege J (2011) The pathogenesis of IgA nephropathy: what is new and how does it change therapeutic approaches? Am J Kidney Dis 58(6):992–1004

    Article  PubMed  CAS  Google Scholar 

  13. Conley ME, Cooper MD, Michael AF (1980) Selective deposition of immunoglobulin A1 in immunoglobulin A nephropathy, anaphylactoid purpura nephritis, and systemic lupus erythematosus. J Clin Invest 66(6):1432–1436

    Article  PubMed  CAS  Google Scholar 

  14. Tomino Y et al (1981) Immunoglobulin A1 and IgA nephropathy. N Engl J Med 305(19):1159–1160

    Article  PubMed  CAS  Google Scholar 

  15. Russell MW et al (1986) IgA-associated renal diseases: antibodies to environmental antigens in sera and deposition of immunoglobulins and antigens in glomeruli. J Clin Immunol 6(1):74–86

    Article  PubMed  CAS  Google Scholar 

  16. Allen AC et al (2001) Mesangial IgA1 in IgA nephropathy exhibits aberrant O-glycosylation: observations in three patients. Kidney Int 60(3):969–973

    Article  PubMed  CAS  Google Scholar 

  17. Hiki Y et al (2001) Mass spectrometry proves under-O-glycosylation of glomerular IgA1 in IgA nephropathy. Kidney Int 59(3):1077–1085

    Article  PubMed  CAS  Google Scholar 

  18. Coppo R, Amore A (2004) Aberrant glycosylation in IgA nephropathy (IgAN). Kidney Int 65(5):1544–1547

    Article  PubMed  CAS  Google Scholar 

  19. Novak J et al (2008) IgA glycosylation and IgA immune complexes in the pathogenesis of IgA nephropathy. Semin Nephrol 28(1):78–87

    Article  PubMed  CAS  Google Scholar 

  20. Tomana M et al (1999) Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies. J Clin Invest 104(1):73–81

    Article  PubMed  CAS  Google Scholar 

  21. Mestecky J et al (2008) Role of aberrant glycosylation of IgA1 molecules in the pathogenesis of IgA nephropathy. Kidney Blood Press Res 31(1):29–37

    Article  PubMed  CAS  Google Scholar 

  22. Novak J et al (2002) Interactions of human mesangial cells with IgA and IgA-containing immune complexes. Kidney Int 62(2):465–475

    Article  PubMed  CAS  Google Scholar 

  23. Novak J et al (2005) IgA1-containing immune complexes in IgA nephropathy differentially affect proliferation of mesangial cells. Kidney Int 67(2):504–513

    Article  PubMed  CAS  Google Scholar 

  24. Shimozato S et al (2008) Serum under-galactosylated IgA1 is increased in Japanese patients with IgA nephropathy. Nephrol Dial Transpl 23(6):1931–1939

    Article  CAS  Google Scholar 

  25. Descamps-Latscha B et al (2004) Early prediction of IgA nephropathy progression: proteinuria and AOPP are strong prognostic markers. Kidney Int 66(4):1606–1612

    Article  PubMed  CAS  Google Scholar 

  26. Durackova Z (2010) Some current insights into oxidative stress. Physiol Res 59(4):459–469

    PubMed  CAS  Google Scholar 

  27. Witko-Sarsat V et al (1996) Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int 49(5):1304–1313

    Article  PubMed  CAS  Google Scholar 

  28. Witko-Sarsat V et al (1998) Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure. J Immunol 161(5):2524–2532

    PubMed  CAS  Google Scholar 

  29. Roberts IS et al (2009) The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility. Kidney Int 76(5):546–556

    Article  PubMed  Google Scholar 

  30. Moriyama, T., et al. (2012) Severity of nephrotic IgA nephropathy according to the Oxford classification. Int Urol Nephrol

  31. Shi XY et al (2008) Advanced oxidation protein products promote inflammation in diabetic kidney through activation of renal nicotinamide adenine dinucleotide phosphate oxidase. Endocrinology 149(4):1829–1839

    Article  PubMed  CAS  Google Scholar 

  32. Liu SX et al (2006) Advanced oxidation protein products accelerate atherosclerosis through promoting oxidative stress and inflammation. Arterioscler Thromb Vasc Biol 26(5):1156–1162

    Article  PubMed  CAS  Google Scholar 

  33. Zuwala-Jagiello J et al (2011) Advanced oxidation protein products and inflammatory markers in liver cirrhosis: a comparison between alcohol-related and HCV-related cirrhosis. Acta Biochim Pol 58(1):59–65

    PubMed  CAS  Google Scholar 

  34. Wei XF et al (2009) Advanced oxidation protein products induce mesangial cell perturbation through PKC-dependent activation of NADPH oxidase. Am J Physiol Renal Physiol 296(2):F427–F437

    Article  PubMed  CAS  Google Scholar 

  35. Zhou LL et al (2009) Accumulation of advanced oxidation protein products induces podocyte apoptosis and deletion through NADPH-dependent mechanisms. Kidney Int 76(11):1148–1160

    Article  PubMed  Google Scholar 

  36. Wen YK (2010) Comparison of prominent glomerular injury and prominent tubular injury in immunoglobulin a nephropathy. Int Urol Nephrol 42(3):753–758

    Article  PubMed  Google Scholar 

  37. Torres DD et al (2008) The ratio of epidermal growth factor to monocyte chemotactic peptide-1 in the urine predicts renal prognosis in IgA nephropathy. Kidney Int 73(3):327–333

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

PRM is supported by grant ME1365/7-1 and SFB854 TP01.

Conflict of interest

None declared.

Author information

Authors and Affiliations

  1. Department of Nephrology and Hypertension, Diabetes and Endocrinology, Otto-von-Guericke-University Magdeburg, Leipziger Strasse 44, 39120, Magdeburg, Germany

    Cheng Zhu & Peter R. Mertens

Authors
  1. Cheng Zhu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Peter R. Mertens
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Peter R. Mertens.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zhu, C., Mertens, P.R. IgA nephropathy and oxidative stress: news on clinically evaluated biomarkers hits the stage. Int Urol Nephrol 44, 1277–1280 (2012). https://doi.org/10.1007/s11255-012-0201-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11255-012-0201-5

Keywords

Search

Navigation